TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

On Wednesday, November 12, the U.S. House of Representatives voted to approve the U.S. Senate’s proposal to reopen the federal government, ending the longest government shutdown in history.

In this message, ASTCT President Dr. David Porter provides an update on the society’s upcoming strategic plan, which will guide ASTCT from 2026 through 2028. He explains the three pillars...

This spotlight features ASTCT Board member Olalekan Oluwole, MD, MPH, a hematologist–oncologist specializing in stem cell transplantation and cellular therapy, and the director of the...

Hematopoietic cell transplantation can be lifesaving, but it’s also one of the most demanding treatments patients and families will ever face. ASTCT’s Palliative and Supportive...

In this episode of ASTCT’s Titans of Transplant series, Dr. Taha Al-Juhaishi welcomes Dr. Sattva Neelapu of MD Anderson Cancer Center for a deep and insightful conversation on the evolution,...

Hill Day 2025: Voices from the Hill On Hill Day 2025, 34 ASTCT members met with 45 House and Senate offices from 21 different states to advocate for increased NIH funding and increased patient...